Solvay SA/NV (0NZR), the Brussels-headquartered specialty chemicals group with €4.3 billion in underlying net sales in 2025, has launched a cash tender offer inviting holders of its outstanding €750 million 3.875% fixed rate bonds due April 2028 to tender up to €375 million in aggregate principal. Concurrently, the company intends to issue €500 million of new seven-year senior unsecured fixed rate euro bonds, subject to market conditions. The dual transaction is designed to proactively manage Solvay's capital structure and debt maturity profile, with offer results expected on 17 November 2026 and settlement anticipated on 19 November 2026.

Key Points

  • Solvay SA (0NZR), listed on Euronext Brussels and Paris under ticker SOLB
  • Tender offer targets up to €375 million of its €750 million 3.875% fixed rate bonds maturing 3 April 2028 (ISIN: BE6350791073)
  • Concurrent planned issuance of €500 million new seven-year senior unsecured fixed rate bonds; offer deadline is 5.00 p.m. CET on 16 November 2026
  • Investors should watch whether the new bond issuance completes successfully, as it is a condition of the tender offer proceeding

Solvay's €375 Million Tender Targets Its April 2028 Fixed Rate Bonds

Solvay announced on 9 November 2026 that it has formally invited eligible bondholders to tender up to €375 million of its existing €750 million 3.875% fixed rate bonds due 3 April 2028. The purchase price will be determined at the pricing time by reference to a fixed purchase spread over the interpolated mid-swap rate, as detailed in the Tender Offer Memorandum dated 9 November 2026. BNP Paribas and BofA Securities Europe SA are acting as Dealer Managers, while Kroll Issuer Services Limited is serving as Tender Agent, with documentation available via a dedicated Kroll portal.

New €500 Million Seven-Year Bond Issuance Is a Condition of the Offer Completing

Completion of the tender offer is explicitly conditional upon the successful issuance of €500 million in new euro-denominated senior unsecured fixed rate bonds with an expected maturity of seven years, subject to market conditions. The announcement states that Solvay may, at its sole discretion, grant bondholders who validly tender their existing bonds priority allocation in the new issue. This structural linkage means that if the new bond placement does not proceed, Solvay is not obliged to purchase any tendered bonds, making the new issue a critical variable for participating holders.

Capital Structure Management Underpins the Rationale for a Pioneering Chemicals Group

Solvay, founded in 1863 and employing around 8,400 people globally, operates across essential chemistry applications ranging from air and water purification to sustainable automotive and textile solutions. The company reported €4.3 billion in underlying net sales in 2025. The announcement states that the dual transaction's purpose is to proactively manage the company's capital structure and debt profile, extending its maturity runway ahead of the 2028 bond redemption date and potentially reducing near-term refinancing risk.

Timeline: Results Expected 17 November, Settlement on 19 November 2026

The tender offer window closes at 5.00 p.m. CET on 16 November 2026 for eligible holders, with results expected to be announced on 17 November 2026. Settlement is anticipated on 19 November 2026. Investors may be watching closely to see whether demand for the concurrent new bond issue is sufficient to satisfy the New Issue Condition and confirm whether the tender proceeds in full, in part, or not at all, given Solvay's sole discretion over final acceptance of tendered bonds.